Correlation
The correlation between IDXX and ZTS is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
IDXX vs. ZTS
Compare and contrast key facts about IDEXX Laboratories, Inc. (IDXX) and Zoetis Inc. (ZTS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IDXX or ZTS.
Performance
IDXX vs. ZTS - Performance Comparison
Loading data...
Key characteristics
IDXX:
0.00
ZTS:
-0.04
IDXX:
0.23
ZTS:
0.05
IDXX:
1.03
ZTS:
1.01
IDXX:
-0.01
ZTS:
-0.06
IDXX:
-0.02
ZTS:
-0.19
IDXX:
13.35%
ZTS:
12.05%
IDXX:
32.15%
ZTS:
25.85%
IDXX:
-81.46%
ZTS:
-46.52%
IDXX:
-26.82%
ZTS:
-30.46%
Fundamentals
IDXX:
$40.34B
ZTS:
$72.38B
IDXX:
$10.83
ZTS:
$5.58
IDXX:
46.31
ZTS:
29.14
IDXX:
4.14
ZTS:
2.77
IDXX:
10.26
ZTS:
7.79
IDXX:
27.86
ZTS:
15.55
IDXX:
$3.93B
ZTS:
$9.29B
IDXX:
$2.41B
ZTS:
$6.52B
IDXX:
$1.29B
ZTS:
$3.98B
Returns By Period
In the year-to-date period, IDXX achieves a 24.93% return, which is significantly higher than ZTS's 2.70% return. Over the past 10 years, IDXX has outperformed ZTS with an annualized return of 22.51%, while ZTS has yielded a comparatively lower 13.67% annualized return.
IDXX
24.93%
18.07%
23.77%
0.00%
9.02%
11.03%
22.51%
ZTS
2.70%
8.33%
-4.76%
-1.14%
-0.17%
4.63%
13.67%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
IDXX vs. ZTS — Risk-Adjusted Performance Rank
IDXX
ZTS
IDXX vs. ZTS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for IDEXX Laboratories, Inc. (IDXX) and Zoetis Inc. (ZTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
IDXX vs. ZTS - Dividend Comparison
IDXX has not paid dividends to shareholders, while ZTS's dividend yield for the trailing twelve months is around 1.12%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
IDXX IDEXX Laboratories, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ZTS Zoetis Inc. | 1.12% | 1.06% | 0.76% | 0.89% | 0.41% | 0.48% | 0.50% | 0.59% | 0.58% | 0.71% | 0.69% | 0.67% |
Drawdowns
IDXX vs. ZTS - Drawdown Comparison
The maximum IDXX drawdown since its inception was -81.46%, which is greater than ZTS's maximum drawdown of -46.52%. Use the drawdown chart below to compare losses from any high point for IDXX and ZTS.
Loading data...
Volatility
IDXX vs. ZTS - Volatility Comparison
IDEXX Laboratories, Inc. (IDXX) and Zoetis Inc. (ZTS) have volatilities of 10.56% and 10.13%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
IDXX vs. ZTS - Financials Comparison
This section allows you to compare key financial metrics between IDEXX Laboratories, Inc. and Zoetis Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IDXX vs. ZTS - Profitability Comparison
IDXX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, IDEXX Laboratories, Inc. reported a gross profit of 623.38M and revenue of 998.43M. Therefore, the gross margin over that period was 62.4%.
ZTS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Zoetis Inc. reported a gross profit of 1.60B and revenue of 2.22B. Therefore, the gross margin over that period was 72.0%.
IDXX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, IDEXX Laboratories, Inc. reported an operating income of 316.53M and revenue of 998.43M, resulting in an operating margin of 31.7%.
ZTS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Zoetis Inc. reported an operating income of 846.00M and revenue of 2.22B, resulting in an operating margin of 38.1%.
IDXX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, IDEXX Laboratories, Inc. reported a net income of 242.68M and revenue of 998.43M, resulting in a net margin of 24.3%.
ZTS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Zoetis Inc. reported a net income of 631.00M and revenue of 2.22B, resulting in a net margin of 28.4%.